This highly successful textbook is now available in its third edition. The book has been extensively updated in order to keep pace with the considerable advances in theory and practice in recent years.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Michael F. Drummond, Professor and Director, Centre for Health Economics, University of York, U.K. Mark J. Sculpher, Professor, Centre for Health Economics, University of York, U.K. George W. Torrance, Professor Centre for Health Economics and Policy Analysis, Centre for Evaluation of Medicines, Department of Clinical Epidemiology and Biostatistics, McMaster University, Ontario, Canada. Bernie J. O'Brien (deceased), Director, Programme for Technology Assessment in Health, Professor, Centre for Evaluation of Medicines, Department of Clinical Epidemiology and Biostatistics, McMaster University, Ontario, Canada. Greg L. Stoddart, Professor, Centre for Health Economics and Policy analysis, Department of Clinical Epidemiology and Biostatistics, McMaster University, Ontario, Canada and Fellow, Canadian Institute for Advanced Research.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Zoom Books Company, Lynden, WA, USA
Zustand: very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service. Bestandsnummer des Verkäufers ZBV.0198529457.VG
Anzahl: 2 verfügbar
Anbieter: World of Books (was SecondSale), Montgomery, IL, USA
Paperback. Zustand: Fair. This highly successful textbook is now available in its third edition. Over the years it has become the standard textbook in the field world-wide. It mirrors the huge expansion of the field of economic evaluation in health care, since the last edition was published in 1997. This new edition builds on the strengths of previous editions, being clearly written in a style accessible to a wide readership. Key methodological principles are outlined using a critical appraisal checklist that can be applied to any published study. The methodological features of the basic forms of analysis are then explained in more detail with special emphasis of the latest views on productivity costs, the characterisation of uncertainty and the concept of net benefit. The book has been greatly revised and expanded especially concerning analysing patient-level data and decision-analytic modelling. There is discussion of new methodological approaches, including cost effectiveness acceptability curves, net benefit regression, probalistic sensitivity analysis and value of information analysis. There is an expanded chapter on the use of economic evaluation, including discussion of the use of cost-effectiveness thresholds, equity considerations and the transferability of economic data. This new edition is required reading for anyone commissioning, undertaking or using economic evaluations in health care, and will be popular with health service professionals, health economists, pharmacand health care decision makers. It is especially relevant for those taking pharmacoeconomics courses. Bestandsnummer des Verkäufers 00100692048
Anzahl: 2 verfügbar
Anbieter: World of Books (was SecondSale), Montgomery, IL, USA
Paperback. Zustand: Very Good. This highly successful textbook is now available in its third edition. Over the years it has become the standard textbook in the field world-wide. It mirrors the huge expansion of the field of economic evaluation in health care, since the last edition was published in 1997. This new edition builds on the strengths of previous editions, being clearly written in a style accessible to a wide readership. Key methodological principles are outlined using a critical appraisal checklist that can be applied to any published study. The methodological features of the basic forms of analysis are then explained in more detail with special emphasis of the latest views on productivity costs, the characterisation of uncertainty and the concept of net benefit. The book has been greatly revised and expanded especially concerning analysing patient-level data and decision-analytic modelling. There is discussion of new methodological approaches, including cost effectiveness acceptability curves, net benefit regression, probalistic sensitivity analysis and value of information analysis. There is an expanded chapter on the use of economic evaluation, including discussion of the use of cost-effectiveness thresholds, equity considerations and the transferability of economic data. This new edition is required reading for anyone commissioning, undertaking or using economic evaluations in health care, and will be popular with health service professionals, health economists, pharmacand health care decision makers. It is especially relevant for those taking pharmacoeconomics courses. Bestandsnummer des Verkäufers 00109662387
Anzahl: 1 verfügbar
Anbieter: BooksRun, Philadelphia, PA, USA
Paperback. Zustand: Fair. 3. The item might be beaten up but readable. May contain markings or highlighting, as well as stains, bent corners, or any other major defect, but the text is not obscured in any way. Bestandsnummer des Verkäufers 0198529457-7-1
Anzahl: 1 verfügbar
Anbieter: Hawking Books, Edgewood, TX, USA
Zustand: Good. Ex-library book with usual markings. Meets or exceeds the good condition guidelines. Nice copy. Five star seller - Buy with confidence! Bestandsnummer des Verkäufers X0198529457X3
Anzahl: 1 verfügbar
Anbieter: World of Books Inc, Montgomery, IL, USA
Paperback. Zustand: Very Good. This highly successful textbook is now available in its third edition. Over the years it has become the standard textbook in the field world-wide. It mirrors the huge expansion of the field of economic evaluation in health care, since the last edition was published in 1997. This new edition builds on the strengths of previous editions, being clearly written in a style accessible to a wide readership. Key methodological principles are outlined using a critical appraisal checklist that can be applied to any published study. The methodological features of the basic forms of analysis are then explained in more detail with special emphasis of the latest views on productivity costs, the characterisation of uncertainty and the concept of net benefit. The book has been greatly revised and expanded especially concerning analysing patient-level data and decision-analytic modelling. There is discussion of new methodological approaches, including cost effectiveness acceptability curves, net benefit regression, probalistic sensitivity analysis and value of information analysis. There is an expanded chapter on the use of economic evaluation, including discussion of the use of cost-effectiveness thresholds, equity considerations and the transferability of economic data. This new edition is required reading for anyone commissioning, undertaking or using economic evaluations in health care, and will be popular with health service professionals, health economists, pharmacand health care decision makers. It is especially relevant for those taking pharmacoeconomics courses. Bestandsnummer des Verkäufers CIN0198529457VG
Anzahl: 1 verfügbar
Anbieter: World of Books Inc, Montgomery, IL, USA
Paperback. Zustand: Fair. This highly successful textbook is now available in its third edition. Over the years it has become the standard textbook in the field world-wide. It mirrors the huge expansion of the field of economic evaluation in health care, since the last edition was published in 1997. This new edition builds on the strengths of previous editions, being clearly written in a style accessible to a wide readership. Key methodological principles are outlined using a critical appraisal checklist that can be applied to any published study. The methodological features of the basic forms of analysis are then explained in more detail with special emphasis of the latest views on productivity costs, the characterisation of uncertainty and the concept of net benefit. The book has been greatly revised and expanded especially concerning analysing patient-level data and decision-analytic modelling. There is discussion of new methodological approaches, including cost effectiveness acceptability curves, net benefit regression, probalistic sensitivity analysis and value of information analysis. There is an expanded chapter on the use of economic evaluation, including discussion of the use of cost-effectiveness thresholds, equity considerations and the transferability of economic data. This new edition is required reading for anyone commissioning, undertaking or using economic evaluations in health care, and will be popular with health service professionals, health economists, pharmacand health care decision makers. It is especially relevant for those taking pharmacoeconomics courses. Bestandsnummer des Verkäufers CIN0198529457A
Anzahl: 2 verfügbar
Anbieter: ThriftBooks-Reno, Reno, NV, USA
Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. Bestandsnummer des Verkäufers G0198529457I4N00
Anzahl: 1 verfügbar
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Paperback. Zustand: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less. Bestandsnummer des Verkäufers G0198529457I5N00
Anzahl: 1 verfügbar
Anbieter: ThriftBooks-Reno, Reno, NV, USA
Paperback. Zustand: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less. Bestandsnummer des Verkäufers G0198529457I5N00
Anzahl: 1 verfügbar